U.S. federal trademark · Serial No. 98123485 · Reg. No. 7709745
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.